Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant. Extracorporeal photopheresis (ECP) can be an effective treatment for certain types of GVHD. This presentation explains how ECP works and its potential benefits for patients with significant GVHD.

Graft-versus-host disease (GVHD) often affects the skin, nails, hair, mouth and/or genitals. This presentation will discuss potential treatments for various forms of acute and chronic skin GVHD, dry skin care, sun protection and how to monitor your skin for skin wounds and skin cancer.

Chronic graft-versus-host disease (GVHD) can affect the skin and underlying tissue. It can also affect the mouth and genitals. Therapies vary depending on the type of skin GVHD a patient is experiencing. People with skin GVHD need to be cautious in the sun and monitor themselves closely for signs of skin cancer.

The skin is the most common organ affected by graft-versus-host disease (GVHD). Treatment options depend on type of GVHD and symptoms

Chronic graft-versus-host disease (GVHD) of the skin is common following a transplant using cells from a donor (allogeneic transplant). It can affect different layers of the skin as well as the mouth, genitals, hair and sweat glands. This presentation discusses the symptoms of skin GVHD and current treatment options. 42 minute presentation followed by 18 minutes of Q&A